
Desonide: A low-potency prescription steroid made for delicate skin. It is the usual step up from hydrocortisone for the face, the folds and young children. Zoryve: A once-daily steroid-free cream for psoriasis, eczema and seborrheic dermatitis. It has no boxed warning and no limit on how long or how much you use it, which is unusual.


Choose as the step up from hydrocortisone for delicate skin — face, eyelids, folds and babies.
Choose for psoriasis, eczema or seborrheic dermatitis when you want a once-daily non-steroid with no limit on time or area.
Can you take them together?
They can share a plan: desonide for short flares and Zoryve for steroid-free maintenance on the face and folds.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.












Activates steroid receptors: Binds receptors inside skin and immune cells. Turns down inflammatory signals: Changes gene activity to reduce inflammatory messengers. Eases redness and itch: Swelling and irritation settle as inflammation falls.
Simplified glucocorticoid receptor-mediated effects in steroid-responsive skin inflammation. Full effects also involve other pathways. No claim of antimicrobial action or cure; formulation and potency affect clinical use.

Blocks PDE4: Inhibits an enzyme that breaks down cAMP. Raises cAMP inside cells: Preserves a signal involved in regulating inflammation. Helps inflamed skin settle: Redness, scaling, and itch can improve.
PDE4 inhibition and increased intracellular cAMP are established. The exact link to clinical improvement is not fully defined; this is a simplified overview, not every downstream pathway.
When to Apply: Twice a day on the affected skin only, in a thin film. One fingertip unit, the amount along the last joint of an adult index finger, covers about two adult palms. Moisturizer goes on separately and continues after the course ends.
How to Start: Twice daily from day one until the rash is flat, not just calmer, usually one to two weeks. Two weeks is the usual limit on a face, up to four weeks on the body before review. In children, follow the prescriber's duration, not the size of the tube.
If It Irritates: Stinging is usually the base, not the drug, and likelier on broken skin or with an alcohol-containing gel or foam. The ointment settles it. Redness or itch that worsens over a week or two can be allergy to the steroid or a preservative, and needs a different product.
If It Is Not Working: Two weeks of proper twice-daily use is a fair test. If nothing changed, question the diagnosis, look for infection, and ask whether the site can take a stronger steroid. On thin skin the better next step is often a non-steroid such as tacrolimus.
When to Apply: Once a day, at a time you will remember. A thin layer over the affected skin, rubbed in. It can go on the face, eyelids, armpits, groin and under the breasts. Moisturizer and sunscreen can go on top once it has absorbed. For the foam, part the hair and apply to the scalp rather than the hair.
How to Start: Once daily from day one, on every affected area. No build-up period, no strength to work through. The common mistake is treating only the worst patches, which makes the result look worse than it is.
If It Irritates: Stinging or mild burning where you apply it settles within a week or two, and moisturizing beforehand helps. Loose stools, headache or feeling slightly sick in the first weeks is a known, usually mild effect of the drug — tell your doctor if it does not pass.
If It's Not Working: Give it 8 weeks of daily use, though itch often eases much sooner. If plaques are unchanged at 8 weeks, the options are a strong steroid for the thickest areas while keeping roflumilast on the rest, adding a vitamin D cream, or moving to light treatment or a systemic medicine. Twice a day does not help.
No blood tests for a standard course in a healthy person. Monitoring is looking at the skin: did the rash clear, has the skin become thin or shiny, have small vessels or stretch marks appeared in the folds.
Children are watched more closely, not because desonide is dangerous but because they absorb proportionally more for their size. Prescribers watch how much is used per month, and whether a repeat pattern has quietly become daily use.
Low potency does not mean indefinite. Where a condition keeps flaring, the plan is short courses on flares with emollients doing the daily work, or a switch to a non-steroid such as tacrolimus or pimecrolimus for the face and folds. Around the eyes, prolonged steroid use of any potency raises the risk of glaucoma and cataract.
No routine blood tests, no boxed warning, no limit on how much body surface you treat, no maximum duration.
What is worth watching has nothing to do with skin. The oral form causes diarrhea, nausea, appetite loss and weight loss in a meaningful number of people, and has been linked to low mood and, rarely, suicidal thoughts. The cream and foam give much lower blood levels, so these are far less common — but they are on the label and your doctor will ask. If you lose weight without trying, or your mood drops, say so.
Otherwise monitoring is a review of whether it is working, around 8 weeks at first. Your doctor will check your history for liver problems, since severe liver impairment rules it out.
Approximate windows, not promises.
First few minutesApplying it: A thin layer on the affected skin. Low potency, which suits the face, the eyelids and small children.
First few minutesApplying it: Once a day. Possible stinging where you apply it, which usually settles.
Days 1 to 3Itch first: Itching and stinging settle before the rash looks different, which is often what lets a child sleep.
Days 3 to 10Clearing: Redness fades and rough or weeping skin settles. Most facial flares are largely better here.
Weeks 1 to 2Judge it here: On the face, stop and reassess here. Facial and eyelid eczema settle without the thinning risk a stronger steroid carries, and seborrheic dermatitis improves in the same window.
Weeks 1 to 2First change: Itch improves first. In seborrheic dermatitis, flaking and redness often start easing here too.
Weeks 2 to 4Folds and the body: Intertrigo and fold rashes respond, and the mildness suits a site that absorbs heavily; any yeast needs treating too. On the body, about four weeks before review.
After stoppingMarks stay behind: Brown or gray patches where the rash was are pigment change, not scarring, and fade over weeks to months.
Week 1Adjusting: A few people get diarrhea, headache or mild nausea. These come from the drug rather than the skin, and are far less common with the cream than the oral version.
Weeks 4 to 8Working: Plaques flatten, scale drops away and redness fades. Week 8 is the fair point to judge plaque psoriasis; eczema and seborrheic dermatitis declare themselves around four weeks. Thinner plaques respond faster.
Folds, face and eyelidsWhere it stands out: These sites absorb steroids quickly and thin fast, so a once-daily option with no time limit changes how they are managed.
After clearingHolding: No thinning, so no reason to stop once skin is clear. Many people continue daily; some drop to a few times a week.
Sorted by what to do about them.
Generic desonide cream, ointment and lotion are cheap and well covered. The branded gel and foam, easier to use on faces and hairy areas, cost considerably more, and plans often ask for a generic first.
It costs more than over-the-counter hydrocortisone, which needs no visit, and less than non-steroids like tacrolimus or crisaborole. If cost is a barrier, start with the cream or ointment.
This is the main reason people do not end up on it. Roflumilast is brand only with no generic, and a tube runs to several hundred dollars or more. Generic steroid creams cost a small fraction of that.
A prior authorization is close to routine. Most plans want to see that a topical steroid was tried and either failed or is not appropriate — the fold, face and eyelid argument usually succeeds, because those are exactly the places long-term steroid use causes harm. Some plans also want a vitamin D cream tried first. Denials are common on the first attempt and often overturned on appeal, so push back.
The manufacturer runs a copay program that can cut the cost substantially with commercial insurance, plus patient assistance for people who qualify. Terms change often. People on government insurance generally cannot use copay cards, which is a real gap.
One practical note: cost is per tube and psoriasis treatment is open-ended, so ask about the largest tube your plan will cover — the price per gram is usually better.
Yes, by a step or two, and both are low potency. Well below mid-potency steroids like triamcinolone.
That is largely what it is for. Keep courses to about two weeks and stop once the rash is flat. Repeated face use is a reason to ask about a non-steroid.
A common choice in children, and some formulations are approved from a few months of age. Follow the prescriber's duration, and remember a diaper acts as a dressing.
A short course at this potency is unlikely to. Thinning comes from stronger steroids, thin sites and long use. Untreated eczema has its own costs: months of scratching and more pigment change.
It can, less readily than stronger steroids. Pale patches show more on deeper skin tones and recover slowly. Untreated inflammation also leaves light and dark marks.
Several steps of potency. Triamcinolone on a face or in a fold for two weeks can cause thinning and stretch marks desonide would not. Matching steroid to site is why both exist.
No. It blocks an enzyme called PDE4 inside inflammatory cells. It does not thin skin, which is why it can go on the face, eyelids and folds without a time limit.
There is no fixed maximum. The rule about stopping after a few weeks comes from steroid creams. Long-term daily use with regular review is normal.
Once daily is what the trials tested. Twice does not clear skin faster and makes stomach side effects more likely.
Usually not. Diarrhea, nausea and headache are listed because they can happen, and are common with the oral version used for lung disease. Blood levels from the cream and foam are much lower.
The drug is the same. The foam lets it spread through hair and over the scalp, and it is the form used for seborrheic dermatitis. The 0.3% cream is for psoriasis and the 0.15% cream for eczema.
Clearing inflammation often leaves a dark or pale patch. Not active disease, and it fades over months. It shows up more on deeper skin tones.
A common approach — a strong steroid for the thickest patches, roflumilast for the face, folds and the rest. Plan it with your doctor rather than layering both on one spot.